In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Gilead’s current price is 24.9% below its PERT-weighted fair value, indicating potential undervaluation supported by strong DCF and analyst target estimates. High profitability and efficiency contrast with moderate leverage and growth scores, signaling stable operations but limited expansion potential. Monte Carlo results reveal significant volatility and a nearly 47% downside risk beneath the current price.